quinic acid has been researched along with Experimental Radiation Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaber, MW; Miller, DD; Thompson, KE; Wilson, CM; Yates, CR; Zeng, K | 1 |
| Haik, BG; Makena, PS; Miller, DD; Steinle, JJ; Toutounchian, JJ; Waters, CM; Wilson, MW; Yates, CR | 1 |
2 other study(ies) available for quinic acid and Experimental Radiation Injuries
| Article | Year |
|---|---|
Quinic acid derivative KZ-41 exhibits radiomitigating activity in preclinical models of radiation injury.
Topics: Animals; Blood Cells; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Mice; Mice, Inbred C57BL; Quinic Acid; Radiation Injuries, Experimental; Radiation-Protective Agents; Tumor Necrosis Factor-alpha; Vascular System Injuries; Venules | 2014 |
Modulation of radiation injury response in retinal endothelial cells by quinic acid derivative KZ-41 involves p38 MAPK.
Topics: Animals; Endothelial Cells; Gamma Rays; Humans; Intercellular Adhesion Molecule-1; MAP Kinase Signaling System; Mice; p38 Mitogen-Activated Protein Kinases; Quinic Acid; Radiation Injuries, Experimental; Retina; Retinal Diseases; Retinal Vessels; Tumor Suppressor Protein p53; U937 Cells | 2014 |